Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Call Transcript 2025

Nov 6, 2025

61700_rns_2025-11-06_d3e56320-6e79-46c2-8802-e96dad83dde3.pdf

Call Transcript

Open in viewer

Opens in your device viewer

November 6, 2025

==> picture [105 x 47] intentionally omitted <==

THRU ONLINE FILING

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB

Dear Sirs,

In accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Conference Call to discuss the Company’s Q2FY26 earnings and business update will be held on Thursday, 13[th] November, 2025 from 16.00 hrs IST.

Please find enclosed herewith the conference call / invite details.

This is for your information / record.

Thanking you

Yours faithfully For Ipca Laboratories Limited

HARISH PANDURANG KAMATH Digitally signed by HARISH PANDURANG KAMATH DN: c=IN, postalCode=400063, st=MAHARASHTRA, street=4204, TOWER B, OBEROI ESQUIRE ,YASHODHAM, MOHAN GOKHALE ROAD ,MUMBAI SUBURBAN,GOREGAON (EAST) ,400063, l=MUMBAI SUBURBAN, o=Personal, serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, pseudonym=cfedd4e63f0643129a1780871ed0cb04, 2.5.4.20=3e5648a57390d9262997da3de9051643bfb87e352b111402af42d207e52e25c6, [email protected], cn=HARISH PANDURANG KAMATH Date: 2025.11.06 12:37:35 +05'30'

Harish P. Kamath Corporate Counsel & Company Secretary ACS 6792

Encl: a/a

==> picture [445 x 70] intentionally omitted <==

==> picture [105 x 47] intentionally omitted <==

INVITE FOR Q2 FY26 EARNINGS CALL OF IPCA LABORATORIES LTD

THURSDAY, 13[TH] NOVEMBER, 2025 AT 16:00 HRS IST

Mumbai, November 6, 2025 : Ipca Laboratories Limited (BSE: 524494, NSE:IPCALAB) will organize a conference call for investors and analysts on Thursday, 13[th] November, 2025 from 16:00 hrs to 17:00 hrs IST to discuss Q2 FY26 earnings and business update. The conference call follows the announcement of the Company’s Q2 FY26 financial results on Thursday, 13[th] November, 2025.

Ipca Laboratories Limited management will be represented by Mr. A K Jain – Managing Director and Mr. Harish Kamath – Corporate Counsel & Company Secretary.

The call will be hosted by Dam Capital Advisors Ltd.

Details of the conference call are as under:

Dial-in numbers

Universal Access: +91-22- 6280 1384 +91-22- 7115 8285

(accessible from all networks and countries)

Diamond Passcode link: Click Here

Please dial-in at least 5-10 minutes prior to the schedule to ensure that you are connected to the call in time.

For further information please contact

Anusha Kawthankar Nitin Agarwal Ipca Laboratories Limited Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) Tel : +91-22-6210 6051 Tel: +91-22-42022568 [email protected] [email protected]

==> picture [445 x 70] intentionally omitted <==